Posted by admin | Posted in | Posted on 20/02/2011
30 Aug 2007 In a letter sent today to the Board of Directors of PDL BioPharma, Inc. (Nasdaq: PDLI), Third Point demanded that L. Patrick Gage
On November 5, 2009, the Board of Directors of the Company appointed L. Patrick Gage, Ph.D. as a new Class I director of the Company. Dr. Gage joins.
Patrick Gage Protein Design Labs Inc. Dir., Interim CEO - Profile From Walker's Research.
5 Jun 2008 Also, Pall plans expansion in South America, Anthony Clarke joins Alexza Pharmaceuticals, more...
Patrick Gage has served as a member of our Board of Directors since November 2009 and as Chairman of the Board of Directors since March 2010.
On November 5, 2009, the Board of Directors of the Company appointed L. Patrick Gage, Ph.D. as a new Class I director of the Company. Dr. Gage joins.
4 Jun 2008 PDL BioPharma director and interim Chief Executive L. Patrick Gage resigned due to differences among the board about prioritizing company
29 Aug 2007 In a letter sent today to the Board of Directors of PDL BioPharma (PDLI), Third Point demanded that L. Patrick Gage immediately resign as
Alvine Pharmaceuticals, Inc., is a privately held biotechnology company focused on autoimmune/ inflammatory diseases.
April 9, 2007 4:42 PM EDT. PDL BioPharma, Inc. (Nasdaq: PDLI) announced that L. Patrick Gage, Ph.D. has been elected as the company's chairman of the board,
Carl L. Gordon, Ph.D, CFA Founding General Partner of OrbiMed and Co-Head of Private Equity. Mr. Gordon is active in both private equity and
22 Jan 2011 22 /PRNewswire/ -- Genetics Institute, Inc. (NASDAQ: GENI) announced today that it has named Garen G. Bohlin, L. Patrick Gage,
On November 5, 2009, the Board of Directors of the Company appointed L. Patrick Gage, Ph.D. as a new Class I director of the Company.
Read the full executive profile of L. Patrick Gage. Find L. Patrick Gage's salary, education, stock options, career history & more biography.
No related posts.